Modern Slavery Act Statement
CVS Group is one of the UK’s leading veterinary providers. CVS Group plc is the parent company of CVS (UK) Limited, which in turn is the owner of a number of trading and non-trading subsidiary companies. Full details of all our subsidiary companies can be found in our latest Annual Report available on our website.
CVS Group’s head office is located in the UK and currently operates in the UK and Australia, with over 8,800 personnel, including c.2,300 veterinary surgeons and c.3,200 nurses.
CVS adopts a strict zero tolerance approach to any form of modern slavery and human trafficking. We endeavour to always act ethically and with integrity in all our business decisions and we expect our suppliers to conduct their business in the same manner.
As the CVS Group continues to grow and our supply chains becomes more complex, our duty to ensure that we are sourcing products ethically and in compliance with the Modern Slavery Act increases. As part of our commitment to achieving this, our Modern Slavery Working Group has continued to monitor where CVS stands in terms of Modern Slavery compliance and supplier due diligence. The Working Group has also developed a Modern Slavery training programme which is to be launched and made mandatory for all CVS employees in Autumn 2025.
We introduced an enhanced Procurement Policy in 2023 which sets out our principles, including that we will always take into account the ethical and social impacts of the goods and services which we purchase.
We have further embedded our Supplier Due Diligence Questionnaires into an automatic onboarding system which mandates relevant businesses to supply their own anti-slavery and human trafficking policy. Where suppliers operate in multiple countries and/or recruit workers from overseas, we require that they also complete a ‘Supplier Labour Force Questionnaire’ which requires a detailed response on all areas of slavery and human trafficking risk within their business.
These actions build on our processes to identify and mitigate modern slavery risks via:
- The maintenance of long-standing relationships with reputable suppliers.
- Prioritising suppliers that have a point of contact within the UK so that they are legally bound by the Modern Slavery Act.
- Where entities in our supply chain operate with a turnover greater than £36 million, we expect them to at the very least have adopted a ‘one-up’ due
diligence on the next link in the chain. Unfortunately, it is not viable for CVS to have a direct relationship with all links in the chain, but we actively encourage and expect transparency where possible. - Our centralised HR function ensures that all our employees receive remuneration appropriately and in compliance with their written contract. The
department has salary review guidelines as well as appropriate and clear Right to Work in the UK and other general HR policies. - CVS actively encourages whistleblowing and the reporting of concerns, whether anonymously or identifiable. This provides CVS with the opportunity to fully
investigate matters and, where relevant, to work with those who have raised concerns to ensure procedures are implemented to prevent further breaches of
our expected standards. We also ensure protection is in place to all whistleblowers. In Autumn 2025, CVS launched an externally operated Whistleblowing
Line for employees to utilise so as to facilitate reporting and compliancethroughout the company. - Our Group Human Resources Director and Group Procurement Director oversee our Anti-Slavery procedures and the implementation of any appropriate policies. They are jointly responsible for reviewing the effectiveness and implementing of amendments where necessary.
In order to conduct business in line with our duties and ethics, CVS has developed appropriate training on modern slavery and human trafficking which is being launched in Autumn 2025. This will ensure that CVS employees become better equipped to spotand identify any cause for concerns and / or risks of human trafficking and modern slavery.
This statement is made pursuant to section 54(1) of the Modern Slavery Act 2015 and constitutes our Group’s Slavery and Human Trafficking statement for the current financial year. It was approved by the Board of Directors on 23 October 2025.
Richard Fairman
Chief Executive Officer
23 October 2025